BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2679637)

  • 1. HLA-B27 and HLA-A2 subtypes: structure, evolution and function.
    López de Castro JA
    Immunol Today; 1989 Jul; 10(7):239-46. PubMed ID: 2679637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
    Calvo V; Rojo S; López D; Galocha B; López de Castro JA
    J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of a functional subtype of HLA-B27. A possible evolutionary pathway for HLA-B27 polymorphism.
    Vega MA; Bragado R; Iványi P; Peláez JL; López de Castro JA
    J Immunol; 1986 Dec; 137(11):3557-65. PubMed ID: 3491141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural polymorphism and function of HLA-B27.
    López de Castro JA
    Curr Opin Rheumatol; 1995 Jul; 7(4):270-8. PubMed ID: 7547103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, function, and disease association of HLA-B27.
    López de Castro JA
    Curr Opin Rheumatol; 1994 Jul; 6(4):371-7. PubMed ID: 8068508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.
    Vega MA; Ezquerra A; Rojo S; Aparicio P; Bragado R; López de Castro JA
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7394-8. PubMed ID: 2414775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B.
    Rojo S; García F; Villadangos JA; López de Castro JA
    J Exp Med; 1993 Mar; 177(3):613-20. PubMed ID: 8436905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and dynamic features of HLA-B27 subtypes.
    Uchanska-Ziegler B; Ziegler A; Schmieder P
    Curr Opin Rheumatol; 2013 Jul; 25(4):411-8. PubMed ID: 23673483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the substitution of critical residues on the allorecognition of HLA-B27.
    Ozen S; Clayberger C; Krensky AM; Benjamin R
    Clin Exp Rheumatol; 1992; 10(6):583-7. PubMed ID: 1282853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27.
    Lamas JR; Brooks JM; Galocha B; Rickinson AB; López de Castro JA
    Int Immunol; 1998 Mar; 10(3):259-66. PubMed ID: 9576613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
    Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
    J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.
    Akram A; Inman RD
    Eur J Immunol; 2013 Dec; 43(12):3254-67. PubMed ID: 24113999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B27 polymorphism in Mumbai, Western India.
    Chhaya SU
    Tissue Antigens; 2005 Jul; 66(1):48-50. PubMed ID: 15982257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens.
    Borenstein SH; Graham J; Zhang XL; Chamberlain JW
    J Immunol; 2000 Sep; 165(5):2341-53. PubMed ID: 10946256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide presentation to an alloreactive CTL clone is modulated through multiple mechanisms involving polymorphic and conserved residues in HLA-B27.
    García-Peydró M; Paradela A; Lamas JR; López De Castro JA
    J Immunol; 1999 Dec; 163(11):6060-4. PubMed ID: 10570294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.
    Buxton SE; Benjamin RJ; Clayberger C; Parham P; Krensky AM
    J Exp Med; 1992 Mar; 175(3):809-20. PubMed ID: 1371304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia.
    Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
    J Immunol; 2001 Sep; 167(6):3375-82. PubMed ID: 11544328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential enhancement of HLA-B27 by interferon.
    Abi-Hanna D; Wakefield D
    Hum Immunol; 1990 Jan; 27(1):33-9. PubMed ID: 1689284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility.
    Fabian H; Huser H; Loll B; Ziegler A; Naumann D; Uchanska-Ziegler B
    Arthritis Rheum; 2010 Apr; 62(4):978-87. PubMed ID: 20131248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.